Laurel Lenz
Concepts (334)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Listeria monocytogenes | 30 | 2021 | 102 | 6.910 |
Why?
| | Listeriosis | 20 | 2021 | 63 | 4.840 |
Why?
| | Killer Cells, Natural | 13 | 2026 | 478 | 2.860 |
Why?
| | Interferon-gamma | 12 | 2019 | 784 | 2.240 |
Why?
| | Interleukin-10 | 5 | 2021 | 309 | 2.110 |
Why?
| | Receptors, Interferon | 8 | 2019 | 60 | 1.860 |
Why?
| | Myeloid Cells | 5 | 2020 | 146 | 1.840 |
Why?
| | Interferon Type I | 7 | 2019 | 147 | 1.490 |
Why?
| | Macrophages | 12 | 2020 | 1500 | 1.350 |
Why?
| | Interleukin-18 | 4 | 2018 | 234 | 1.190 |
Why?
| | Streptococcus pneumoniae | 2 | 2020 | 180 | 1.090 |
Why?
| | Dendritic Cells | 10 | 2026 | 496 | 1.070 |
Why?
| | Immunity, Innate | 13 | 2026 | 834 | 1.030 |
Why?
| | Bacterial Infections | 4 | 2018 | 246 | 0.930 |
Why?
| | Interferon-beta | 3 | 2018 | 92 | 0.920 |
Why?
| | Bacterial Proteins | 9 | 2018 | 962 | 0.890 |
Why?
| | Host-Pathogen Interactions | 3 | 2020 | 361 | 0.840 |
Why?
| | Interferon-alpha | 2 | 2018 | 193 | 0.800 |
Why?
| | Mice, Inbred C57BL | 21 | 2021 | 5972 | 0.740 |
Why?
| | Animals | 52 | 2022 | 37952 | 0.740 |
Why?
| | Repressor Proteins | 2 | 2018 | 429 | 0.740 |
Why?
| | STAT3 Transcription Factor | 3 | 2022 | 206 | 0.720 |
Why?
| | Mice | 41 | 2022 | 18303 | 0.720 |
Why?
| | Mice, Knockout | 15 | 2021 | 3114 | 0.700 |
Why?
| | Leukocytes, Mononuclear | 2 | 2025 | 573 | 0.670 |
Why?
| | Interleukin-15 | 2 | 2019 | 95 | 0.660 |
Why?
| | Casein Kinase II | 1 | 2020 | 22 | 0.660 |
Why?
| | Bacteria | 3 | 2018 | 765 | 0.610 |
Why?
| | Pneumonia, Pneumococcal | 1 | 2020 | 47 | 0.600 |
Why?
| | N-Acetylmuramoyl-L-alanine Amidase | 3 | 2009 | 5 | 0.600 |
Why?
| | Radiation Injuries | 2 | 2011 | 149 | 0.590 |
Why?
| | Orthomyxoviridae Infections | 1 | 2020 | 71 | 0.590 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 2 | 2018 | 166 | 0.580 |
Why?
| | Lymphocyte Activation | 4 | 2016 | 1131 | 0.580 |
Why?
| | Influenza A virus | 1 | 2020 | 116 | 0.580 |
Why?
| | Pneumococcal Infections | 1 | 2020 | 103 | 0.570 |
Why?
| | Coinfection | 1 | 2020 | 143 | 0.550 |
Why?
| | Macrophage Activation | 4 | 2017 | 181 | 0.550 |
Why?
| | Basic-Leucine Zipper Transcription Factors | 1 | 2018 | 43 | 0.540 |
Why?
| | Streptococcal Infections | 1 | 2020 | 171 | 0.530 |
Why?
| | Disease Susceptibility | 4 | 2021 | 343 | 0.510 |
Why?
| | Flow Cytometry | 4 | 2016 | 1159 | 0.450 |
Why?
| | Pneumonia | 1 | 2021 | 635 | 0.440 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 388 | 0.430 |
Why?
| | Bacterial Vaccines | 2 | 2020 | 63 | 0.430 |
Why?
| | Respiratory Syncytial Virus, Human | 2 | 2026 | 81 | 0.420 |
Why?
| | Adenosine Triphosphatases | 3 | 2007 | 159 | 0.420 |
Why?
| | T-Lymphocytes, Cytotoxic | 6 | 2007 | 177 | 0.410 |
Why?
| | Argon Plasma Coagulation | 2 | 2011 | 6 | 0.400 |
Why?
| | Early Growth Response Protein 3 | 1 | 2013 | 1 | 0.400 |
Why?
| | Influenza, Human | 1 | 2020 | 624 | 0.400 |
Why?
| | Respiratory Syncytial Virus Infections | 2 | 2026 | 139 | 0.400 |
Why?
| | Lung Diseases | 1 | 2020 | 780 | 0.390 |
Why?
| | Interferon Regulatory Factor-3 | 3 | 2011 | 16 | 0.390 |
Why?
| | Radiotherapy | 2 | 2011 | 204 | 0.390 |
Why?
| | Antigens, Bacterial | 4 | 1998 | 126 | 0.380 |
Why?
| | Gene Silencing | 1 | 2013 | 202 | 0.370 |
Why?
| | H-2 Antigens | 3 | 1997 | 111 | 0.370 |
Why?
| | Gene Expression | 3 | 2019 | 1474 | 0.370 |
Why?
| | Anthrax | 1 | 2012 | 9 | 0.360 |
Why?
| | Bacillus anthracis | 1 | 2012 | 13 | 0.360 |
Why?
| | Toll-Like Receptors | 3 | 2012 | 193 | 0.360 |
Why?
| | Membrane Transport Proteins | 2 | 2003 | 153 | 0.350 |
Why?
| | Lymph Nodes | 2 | 2012 | 502 | 0.350 |
Why?
| | Telangiectasis | 1 | 2011 | 7 | 0.340 |
Why?
| | Membrane Proteins | 5 | 2021 | 1163 | 0.340 |
Why?
| | Cyclic GMP | 1 | 2011 | 90 | 0.340 |
Why?
| | Sigmoid Diseases | 1 | 2011 | 14 | 0.340 |
Why?
| | Rectal Diseases | 1 | 2011 | 24 | 0.340 |
Why?
| | Peptidoglycan | 2 | 2009 | 28 | 0.340 |
Why?
| | Electrocoagulation | 1 | 2011 | 35 | 0.340 |
Why?
| | Inflammasomes | 1 | 2012 | 144 | 0.330 |
Why?
| | Lung | 3 | 2019 | 4101 | 0.330 |
Why?
| | Escherichia coli Proteins | 2 | 2003 | 201 | 0.330 |
Why?
| | Cyclic AMP | 1 | 2011 | 207 | 0.320 |
Why?
| | Proctocolitis | 1 | 2010 | 1 | 0.320 |
Why?
| | Interleukin-1beta | 1 | 2012 | 390 | 0.320 |
Why?
| | Cells, Cultured | 6 | 2019 | 4142 | 0.310 |
Why?
| | Inflammation | 4 | 2026 | 2876 | 0.310 |
Why?
| | Gastrointestinal Hemorrhage | 1 | 2011 | 138 | 0.310 |
Why?
| | Recombinant Proteins | 3 | 2011 | 1368 | 0.300 |
Why?
| | Down-Regulation | 5 | 2019 | 618 | 0.300 |
Why?
| | Antigens | 1 | 2011 | 348 | 0.290 |
Why?
| | CD5 Antigens | 1 | 2009 | 10 | 0.290 |
Why?
| | Mice, Transgenic | 5 | 2021 | 2185 | 0.290 |
Why?
| | Mice, Inbred BALB C | 9 | 2012 | 1261 | 0.290 |
Why?
| | Bone Marrow Cells | 3 | 2010 | 320 | 0.270 |
Why?
| | Lymphocytes | 2 | 2014 | 376 | 0.270 |
Why?
| | Intubation, Intratracheal | 1 | 2011 | 325 | 0.270 |
Why?
| | Cell Communication | 1 | 2010 | 328 | 0.270 |
Why?
| | Bacteremia | 1 | 2010 | 222 | 0.260 |
Why?
| | Recombination, Genetic | 1 | 2008 | 203 | 0.260 |
Why?
| | Nitric Oxide | 1 | 2012 | 892 | 0.250 |
Why?
| | Antigen Presentation | 3 | 1998 | 207 | 0.250 |
Why?
| | Genetic Vectors | 1 | 2008 | 335 | 0.250 |
Why?
| | Lipopolysaccharides | 3 | 2021 | 858 | 0.250 |
Why?
| | Genes, Bacterial | 2 | 2008 | 152 | 0.250 |
Why?
| | Host-Parasite Interactions | 1 | 2007 | 110 | 0.250 |
Why?
| | B-Lymphocytes | 1 | 2012 | 866 | 0.240 |
Why?
| | Head and Neck Neoplasms | 2 | 2021 | 561 | 0.240 |
Why?
| | Coculture Techniques | 3 | 2025 | 247 | 0.240 |
Why?
| | Selection, Genetic | 1 | 2008 | 259 | 0.240 |
Why?
| | Female | 20 | 2026 | 78636 | 0.230 |
Why?
| | Communicable Diseases | 1 | 2007 | 166 | 0.220 |
Why?
| | Virulence | 5 | 2008 | 278 | 0.220 |
Why?
| | Cytokines | 6 | 2025 | 2048 | 0.220 |
Why?
| | Respiratory Syncytial Viruses | 1 | 2025 | 58 | 0.220 |
Why?
| | Epitopes | 2 | 1997 | 473 | 0.210 |
Why?
| | Cytotoxicity, Immunologic | 3 | 2003 | 224 | 0.200 |
Why?
| | Male | 14 | 2026 | 72664 | 0.190 |
Why?
| | Cell Line | 5 | 2012 | 2821 | 0.190 |
Why?
| | Humans | 23 | 2026 | 145140 | 0.180 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2016 | 847 | 0.180 |
Why?
| | Radioimmunotherapy | 1 | 2021 | 25 | 0.170 |
Why?
| | Disease Models, Animal | 3 | 2020 | 4552 | 0.170 |
Why?
| | Ligands | 4 | 2019 | 664 | 0.170 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2026 | 438 | 0.170 |
Why?
| | Mouth Diseases | 1 | 2021 | 47 | 0.160 |
Why?
| | Vaccinia | 1 | 2000 | 20 | 0.160 |
Why?
| | Lymphocytic Choriomeningitis | 1 | 2000 | 25 | 0.160 |
Why?
| | Respiratory Tract Infections | 1 | 2025 | 394 | 0.160 |
Why?
| | Transcription, Genetic | 2 | 2019 | 1454 | 0.160 |
Why?
| | Antigen-Presenting Cells | 1 | 2000 | 159 | 0.160 |
Why?
| | Legionnaires' Disease | 1 | 2019 | 4 | 0.160 |
Why?
| | Legionella pneumophila | 1 | 2019 | 3 | 0.160 |
Why?
| | Bites and Stings | 1 | 2020 | 30 | 0.150 |
Why?
| | Malaria, Cerebral | 1 | 2019 | 5 | 0.150 |
Why?
| | Amino Acid Sequence | 6 | 2009 | 2127 | 0.150 |
Why?
| | CD4 Antigens | 1 | 2019 | 137 | 0.150 |
Why?
| | Signal Transduction | 6 | 2019 | 5208 | 0.140 |
Why?
| | STAT4 Transcription Factor | 1 | 2018 | 3 | 0.140 |
Why?
| | Enhancer Elements, Genetic | 1 | 2019 | 191 | 0.140 |
Why?
| | Carcinoma, Pancreatic Ductal | 1 | 2022 | 293 | 0.140 |
Why?
| | Solubility | 1 | 2018 | 240 | 0.130 |
Why?
| | Interleukin-2 | 1 | 2018 | 440 | 0.120 |
Why?
| | Monocytes | 1 | 2019 | 537 | 0.120 |
Why?
| | Disease Progression | 2 | 2022 | 2857 | 0.120 |
Why?
| | Macrophages, Alveolar | 1 | 2019 | 373 | 0.120 |
Why?
| | Blotting, Western | 2 | 2013 | 1177 | 0.120 |
Why?
| | Survival Analysis | 1 | 2019 | 1371 | 0.120 |
Why?
| | NF-kappa B | 1 | 2019 | 664 | 0.120 |
Why?
| | Adoptive Transfer | 1 | 2016 | 199 | 0.120 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2018 | 265 | 0.110 |
Why?
| | Chromatin | 1 | 2019 | 553 | 0.110 |
Why?
| | Phosphorylation | 2 | 2010 | 1706 | 0.110 |
Why?
| | Infant | 4 | 2026 | 10060 | 0.110 |
Why?
| | Genotype | 1 | 2020 | 1844 | 0.110 |
Why?
| | Adenocarcinoma | 1 | 2022 | 920 | 0.110 |
Why?
| | Breeding | 1 | 2014 | 63 | 0.110 |
Why?
| | Chronic Disease | 2 | 2011 | 1806 | 0.110 |
Why?
| | Housing, Animal | 1 | 2014 | 46 | 0.100 |
Why?
| | Antibodies, Monoclonal, Murine-Derived | 1 | 2013 | 95 | 0.100 |
Why?
| | Pancreatic Neoplasms | 1 | 2022 | 926 | 0.100 |
Why?
| | SEC Translocation Channels | 2 | 2003 | 9 | 0.100 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2013 | 139 | 0.100 |
Why?
| | T-Lymphocyte Subsets | 2 | 2007 | 417 | 0.100 |
Why?
| | Molecular Sequence Data | 5 | 2004 | 2881 | 0.090 |
Why?
| | Interleukin-12 | 3 | 2011 | 115 | 0.090 |
Why?
| | Caspases, Initiator | 1 | 2012 | 16 | 0.090 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2013 | 337 | 0.090 |
Why?
| | Reactive Oxygen Species | 2 | 2012 | 611 | 0.090 |
Why?
| | Spores, Bacterial | 1 | 2012 | 18 | 0.090 |
Why?
| | Receptors, CCR7 | 1 | 2012 | 32 | 0.090 |
Why?
| | Phagosomes | 1 | 2012 | 40 | 0.090 |
Why?
| | Caspase 1 | 1 | 2012 | 146 | 0.090 |
Why?
| | Myeloid Differentiation Factor 88 | 2 | 2010 | 118 | 0.090 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2012 | 162 | 0.090 |
Why?
| | Lymphocyte Depletion | 1 | 2012 | 131 | 0.090 |
Why?
| | Caspases | 1 | 2012 | 233 | 0.090 |
Why?
| | Receptors, Complement | 1 | 2012 | 122 | 0.090 |
Why?
| | Instillation, Drug | 1 | 2011 | 9 | 0.090 |
Why?
| | Receptors, Antigen, B-Cell | 1 | 2012 | 130 | 0.090 |
Why?
| | Francisella tularensis | 1 | 2011 | 33 | 0.080 |
Why?
| | Immunologic Factors | 1 | 2013 | 260 | 0.080 |
Why?
| | Colon, Sigmoid | 1 | 2011 | 21 | 0.080 |
Why?
| | Intention to Treat Analysis | 1 | 2011 | 79 | 0.080 |
Why?
| | Vesiculovirus | 1 | 2011 | 17 | 0.080 |
Why?
| | Aged | 4 | 2020 | 26096 | 0.080 |
Why?
| | Adaptive Immunity | 1 | 2012 | 167 | 0.080 |
Why?
| | Phagocytes | 1 | 2011 | 80 | 0.080 |
Why?
| | Cell Death | 1 | 2012 | 382 | 0.080 |
Why?
| | Immunotherapy | 1 | 2016 | 665 | 0.080 |
Why?
| | Immunoglobulin M | 1 | 2012 | 265 | 0.080 |
Why?
| | TRPM Cation Channels | 1 | 2011 | 73 | 0.080 |
Why?
| | Gastrointestinal Microbiome | 1 | 2018 | 766 | 0.080 |
Why?
| | STAT1 Transcription Factor | 1 | 2010 | 66 | 0.080 |
Why?
| | HIV Infections | 1 | 2026 | 3186 | 0.080 |
Why?
| | Melanoma, Experimental | 1 | 2011 | 109 | 0.080 |
Why?
| | Immunologic Memory | 2 | 2007 | 368 | 0.080 |
Why?
| | Rectum | 1 | 2011 | 182 | 0.080 |
Why?
| | Base Sequence | 4 | 2004 | 2168 | 0.080 |
Why?
| | Histocompatibility Antigens Class I | 2 | 2003 | 202 | 0.080 |
Why?
| | Toll-Like Receptor 2 | 2 | 2007 | 125 | 0.070 |
Why?
| | Gene Deletion | 2 | 2008 | 391 | 0.070 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 977 | 0.070 |
Why?
| | Receptors, Cell Surface | 2 | 2009 | 372 | 0.070 |
Why?
| | Spleen | 2 | 2008 | 507 | 0.070 |
Why?
| | Mycobacterium Infections, Nontuberculous | 1 | 2013 | 339 | 0.070 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2010 | 364 | 0.070 |
Why?
| | Alanine Racemase | 1 | 2008 | 2 | 0.070 |
Why?
| | Endometrial Neoplasms | 1 | 2011 | 205 | 0.070 |
Why?
| | Glutamate-Ammonia Ligase | 1 | 2008 | 8 | 0.070 |
Why?
| | Genetic Complementation Test | 1 | 2008 | 72 | 0.070 |
Why?
| | T-Lymphocytes, Regulatory | 2 | 2022 | 407 | 0.070 |
Why?
| | Carrier Proteins | 1 | 2012 | 728 | 0.070 |
Why?
| | AIDS Vaccines | 1 | 2008 | 53 | 0.070 |
Why?
| | CD8-Positive T-Lymphocytes | 4 | 2008 | 917 | 0.070 |
Why?
| | Aged, 80 and over | 2 | 2011 | 8318 | 0.070 |
Why?
| | Uterine Cervical Neoplasms | 1 | 2011 | 268 | 0.070 |
Why?
| | Group IV Phospholipases A2 | 1 | 2007 | 46 | 0.070 |
Why?
| | Hemolysin Proteins | 1 | 2007 | 36 | 0.070 |
Why?
| | Vaccines, Attenuated | 1 | 2008 | 129 | 0.070 |
Why?
| | Macrophages, Peritoneal | 1 | 2007 | 89 | 0.070 |
Why?
| | Liver | 3 | 2018 | 1893 | 0.070 |
Why?
| | Mutation | 4 | 2010 | 4071 | 0.060 |
Why?
| | Bacterial Toxins | 1 | 2007 | 108 | 0.060 |
Why?
| | Plasmids | 1 | 2008 | 373 | 0.060 |
Why?
| | Immunotherapy, Adoptive | 1 | 2011 | 342 | 0.060 |
Why?
| | Heat-Shock Proteins | 1 | 2007 | 139 | 0.060 |
Why?
| | Bystander Effect | 1 | 2007 | 19 | 0.060 |
Why?
| | Tumor Microenvironment | 2 | 2021 | 733 | 0.060 |
Why?
| | Fungi | 1 | 2007 | 121 | 0.060 |
Why?
| | Biological Transport | 1 | 2007 | 423 | 0.060 |
Why?
| | Protein Structure, Tertiary | 1 | 2009 | 855 | 0.060 |
Why?
| | Virulence Factors | 1 | 2007 | 174 | 0.060 |
Why?
| | Autoantibodies | 1 | 2013 | 1508 | 0.060 |
Why?
| | Antibodies | 1 | 2007 | 397 | 0.060 |
Why?
| | Antigens, CD1 | 1 | 2005 | 60 | 0.050 |
Why?
| | Alleles | 2 | 2020 | 888 | 0.050 |
Why?
| | Obesity | 1 | 2018 | 3097 | 0.050 |
Why?
| | A549 Cells | 1 | 2025 | 74 | 0.050 |
Why?
| | Adult | 4 | 2026 | 40665 | 0.050 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2007 | 337 | 0.050 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 2004 | 161 | 0.050 |
Why?
| | Autolysis | 1 | 2003 | 3 | 0.050 |
Why?
| | CD4-Positive T-Lymphocytes | 2 | 2007 | 1138 | 0.050 |
Why?
| | Prostatic Neoplasms | 1 | 2011 | 978 | 0.050 |
Why?
| | Fetal Blood | 1 | 2026 | 325 | 0.050 |
Why?
| | Infant, Newborn | 2 | 2026 | 6435 | 0.050 |
Why?
| | Gene Expression Profiling | 1 | 2010 | 1763 | 0.050 |
Why?
| | Pregnancy | 3 | 2026 | 7182 | 0.050 |
Why?
| | Immunity, Cellular | 1 | 2025 | 273 | 0.050 |
Why?
| | Severity of Illness Index | 1 | 2011 | 2928 | 0.050 |
Why?
| | Interleukin-6 | 1 | 2007 | 775 | 0.050 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2002 | 387 | 0.040 |
Why?
| | Cloning, Molecular | 1 | 2002 | 537 | 0.040 |
Why?
| | DNA Primers | 1 | 2002 | 505 | 0.040 |
Why?
| | T-Lymphocytes | 2 | 2007 | 1993 | 0.040 |
Why?
| | Chimera | 1 | 2000 | 60 | 0.040 |
Why?
| | Vaccinia virus | 1 | 2000 | 35 | 0.040 |
Why?
| | Nucleoproteins | 1 | 2000 | 38 | 0.040 |
Why?
| | Lymphocytic choriomeningitis virus | 1 | 2000 | 36 | 0.040 |
Why?
| | Cell Movement | 1 | 2005 | 959 | 0.040 |
Why?
| | Neoplasms | 1 | 2016 | 2900 | 0.040 |
Why?
| | Nucleotides, Cyclic | 1 | 2020 | 22 | 0.040 |
Why?
| | Gene Knock-In Techniques | 1 | 2020 | 61 | 0.040 |
Why?
| | Major Histocompatibility Complex | 1 | 2000 | 233 | 0.040 |
Why?
| | Fibroblasts | 1 | 2025 | 1022 | 0.040 |
Why?
| | Germ-Free Life | 1 | 2018 | 33 | 0.040 |
Why?
| | Fatty Acids, Volatile | 1 | 2018 | 60 | 0.030 |
Why?
| | Middle Aged | 2 | 2011 | 36126 | 0.030 |
Why?
| | Diet, Western | 1 | 2018 | 88 | 0.030 |
Why?
| | Phenotype | 2 | 2005 | 3138 | 0.030 |
Why?
| | Prospective Studies | 1 | 2010 | 8035 | 0.030 |
Why?
| | Bile Acids and Salts | 1 | 2018 | 163 | 0.030 |
Why?
| | Polymorphism, Genetic | 1 | 2020 | 614 | 0.030 |
Why?
| | Dysbiosis | 1 | 2018 | 187 | 0.030 |
Why?
| | Transformation, Bacterial | 1 | 1996 | 10 | 0.030 |
Why?
| | Proteomics | 1 | 2003 | 1185 | 0.030 |
Why?
| | Gene Library | 1 | 1996 | 122 | 0.030 |
Why?
| | Treatment Outcome | 1 | 2011 | 11741 | 0.030 |
Why?
| | Feces | 1 | 2018 | 494 | 0.030 |
Why?
| | Adiposity | 1 | 2018 | 532 | 0.030 |
Why?
| | Intestinal Mucosa | 1 | 2018 | 674 | 0.020 |
Why?
| | Rituximab | 1 | 2013 | 210 | 0.020 |
Why?
| | Polyomaviridae | 1 | 1992 | 1 | 0.020 |
Why?
| | Guidelines as Topic | 1 | 2014 | 266 | 0.020 |
Why?
| | Parrots | 1 | 1992 | 2 | 0.020 |
Why?
| | Bird Diseases | 1 | 1992 | 16 | 0.020 |
Why?
| | Mothers | 1 | 2018 | 764 | 0.020 |
Why?
| | Capsid | 1 | 1992 | 93 | 0.020 |
Why?
| | Papillomaviridae | 1 | 1992 | 115 | 0.020 |
Why?
| | Interleukin-12 Receptor beta 2 Subunit | 1 | 2011 | 1 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2007 | 1216 | 0.020 |
Why?
| | Disulfides | 1 | 2010 | 94 | 0.020 |
Why?
| | Dimerization | 1 | 2010 | 189 | 0.020 |
Why?
| | Body Weight | 1 | 2014 | 969 | 0.020 |
Why?
| | Genes, Reporter | 1 | 2010 | 277 | 0.020 |
Why?
| | Adjuvants, Immunologic | 1 | 2011 | 243 | 0.020 |
Why?
| | Cancer Vaccines | 1 | 2011 | 161 | 0.020 |
Why?
| | Child, Preschool | 1 | 2025 | 11835 | 0.020 |
Why?
| | Cysteine | 1 | 2010 | 210 | 0.020 |
Why?
| | Autoimmunity | 1 | 2014 | 932 | 0.020 |
Why?
| | Antibodies, Viral | 1 | 1992 | 673 | 0.020 |
Why?
| | Indomethacin | 1 | 2007 | 76 | 0.020 |
Why?
| | Mice, Inbred ICR | 1 | 2007 | 113 | 0.020 |
Why?
| | Arachidonic Acids | 1 | 2007 | 42 | 0.020 |
Why?
| | Cyclooxygenase Inhibitors | 1 | 2007 | 82 | 0.020 |
Why?
| | Cyclooxygenase 2 | 1 | 2007 | 166 | 0.020 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2007 | 174 | 0.020 |
Why?
| | Cytosol | 1 | 2007 | 212 | 0.010 |
Why?
| | Enzyme Activation | 1 | 2007 | 762 | 0.010 |
Why?
| | MAP Kinase Signaling System | 1 | 2007 | 307 | 0.010 |
Why?
| | Calcium Signaling | 1 | 2007 | 244 | 0.010 |
Why?
| | Neutrophils | 1 | 2011 | 1123 | 0.010 |
Why?
| | Adolescent | 1 | 2025 | 22479 | 0.010 |
Why?
| | Antigens, CD1d | 1 | 2005 | 69 | 0.010 |
Why?
| | Mycobacterium bovis | 1 | 2004 | 15 | 0.010 |
Why?
| | Muromegalovirus | 1 | 2004 | 22 | 0.010 |
Why?
| | Antibodies, Monoclonal | 1 | 1992 | 1505 | 0.010 |
Why?
| | Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2004 | 31 | 0.010 |
Why?
| | Child | 1 | 2025 | 22670 | 0.010 |
Why?
| | TNF-Related Apoptosis-Inducing Ligand | 1 | 2004 | 54 | 0.010 |
Why?
| | Interleukin-4 | 1 | 2005 | 207 | 0.010 |
Why?
| | Mast-Cell Sarcoma | 1 | 2003 | 6 | 0.010 |
Why?
| | Immunodominant Epitopes | 1 | 2003 | 27 | 0.010 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2004 | 187 | 0.010 |
Why?
| | Injections, Intravenous | 1 | 2003 | 197 | 0.010 |
Why?
| | Herpesviridae Infections | 1 | 2004 | 148 | 0.010 |
Why?
| | Clone Cells | 1 | 2003 | 263 | 0.010 |
Why?
| | Sequence Deletion | 1 | 2003 | 190 | 0.010 |
Why?
| | Epitopes, T-Lymphocyte | 1 | 2003 | 174 | 0.010 |
Why?
| | Membrane Glycoproteins | 1 | 2004 | 499 | 0.010 |
Why?
| | Calcium | 1 | 2007 | 1189 | 0.010 |
Why?
| | Microfilament Proteins | 1 | 2001 | 135 | 0.010 |
Why?
| | Cell Adhesion Molecules | 1 | 2001 | 181 | 0.010 |
Why?
| | Phosphoproteins | 1 | 2001 | 337 | 0.010 |
Why?
| | Mice, Inbred DBA | 1 | 1998 | 182 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2003 | 3539 | 0.010 |
Why?
| | Time Factors | 1 | 2004 | 7107 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2001 | 3410 | 0.010 |
Why?
| | Chick Embryo | 1 | 1992 | 132 | 0.010 |
Why?
| | Peptides | 1 | 1998 | 997 | 0.010 |
Why?
| | Hybridomas | 1 | 1992 | 233 | 0.010 |
Why?
|
|
Lenz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|